Literature DB >> 16323133

Molecular analysis of respiratory syncytial virus reinfections in infants from coastal Kenya.

Paul D Scott1, Rachel Ochola, Mwanajuma Ngama, Emelda A Okiro, D James Nokes, Graham F Medley, Patricia A Cane.   

Abstract

BACKGROUND: Individuals are reinfected with respiratory syncytial virus (RSV) repeatedly. The nature of reinfection, in relation to RSV genetic and antigenic diversity, is ill defined and has implications for persistence and vaccine control. <br> METHODS: We examined the molecular relatedness of RSV causing primary and repeat infections, by phylogenetic analysis of the attachment (G) gene in 12 infants from a birth cohort in rural Kenya, using nasal wash samples collected during a 16-month period in 2002-2003, which spanned 2 successive epidemics. <br> RESULTS: Six infants were infected during both epidemics, 4 with RSV-A in the first epidemic followed by RSV-B during the second epidemic and 2 with RSV-A during both epidemics, with no significant G gene sequence variability between samples. Two infants were infected and reinfected with different RSV-A strains during the same epidemic. Possible viral persistence was suspected in the remaining 4 infants, although reinfection with the same variant cannot be excluded. <br> CONCLUSIONS: These are the first data that specifically address strain-specific reinfections in infancy in relation to the primary infecting variant. The data strongly suggest that, following primary infection, some infants lose strain-specific immunity within 7-9 months (between epidemics) and group-specific immunity within 2-4 months (during an epidemic period).

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16323133      PMCID: PMC2384051          DOI: 10.1086/498246

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  27 in total

1.  Major changes in the G protein of human respiratory syncytial virus isolates introduced by a duplication of 60 nucleotides.

Authors:  Alfonsina Trento; Mónica Galiano; Cristina Videla; Guadalupe Carballal; Blanca García-Barreno; José A Melero; Concepción Palomo
Journal:  J Gen Virol       Date:  2003-11       Impact factor: 3.891

2.  Epidemiology and clinical presentation of respiratory syncytial virus infection in a rural area of southern Mozambique.

Authors:  Maria P Loscertales; Anna Roca; Pere J Ventura; Fátima Abacassamo; Francisco Dos Santos; Mariano Sitaube; Clara Men ndez; Brian M Greenwood; Juan C Saiz; Pedro L Alonso
Journal:  Pediatr Infect Dis J       Date:  2002-02       Impact factor: 2.129

3.  Genetic diversity and molecular epidemiology of respiratory syncytial virus over four consecutive seasons in South Africa: identification of new subgroup A and B genotypes.

Authors:  Marietjie Venter; Shabir A Madhi; Caroline T Tiemessen; Barry D Schoub
Journal:  J Gen Virol       Date:  2001-09       Impact factor: 3.891

4.  Respiratory syncytial virus epidemiology in a birth cohort from Kilifi district, Kenya: infection during the first year of life.

Authors:  D James Nokes; Emelda A Okiro; Mwanajuma Ngama; Lisa J White; Rachel Ochola; Paul D Scott; Patricia A Cane; Graham F Medley
Journal:  J Infect Dis       Date:  2004-10-08       Impact factor: 5.226

5.  Molecular epidemiology of respiratory syncytial virus in Kilifi district, Kenya.

Authors:  Paul D Scott; Rachel Ochola; Mwanajuma Ngama; Emelda A Okiro; D James Nokes; Graham F Medley; Patricia A Cane
Journal:  J Med Virol       Date:  2004-10       Impact factor: 2.327

6.  Nosocomial outbreak of respiratory syncytial virus subgroup B variants with the 60 nucleotides-duplicated G protein gene.

Authors:  Kazushige Nagai; Hotaka Kamasaki; Yuki Kuroiwa; Lisa Okita; Hiroyuki Tsutsumi
Journal:  J Med Virol       Date:  2004-09       Impact factor: 2.327

7.  Respiratory-syncytial-virus infections, reinfections and immunity. A prospective, longitudinal study in young children.

Authors:  F W Henderson; A M Collier; W A Clyde; F W Denny
Journal:  N Engl J Med       Date:  1979-03-08       Impact factor: 91.245

8.  Role of serum neutralizing antibody in reinfection of respiratory syncytial virus.

Authors:  Yukihiko Kawasaki; Mitsuaki Hosoya; Masahiko Katayose; Hitoshi Suzuki
Journal:  Pediatr Int       Date:  2004-04       Impact factor: 1.524

9.  Risk of primary infection and reinfection with respiratory syncytial virus.

Authors:  W P Glezen; L H Taber; A L Frank; J A Kasel
Journal:  Am J Dis Child       Date:  1986-06

10.  Molecular evolution and circulation patterns of human respiratory syncytial virus subgroup a: positively selected sites in the attachment g glycoprotein.

Authors:  Kalina T Zlateva; Philippe Lemey; Anne-Mieke Vandamme; Marc Van Ranst
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

View more
  28 in total

1.  Co-immunization with virus-like particle and DNA vaccines induces protection against respiratory syncytial virus infection and bronchiolitis.

Authors:  Hye Suk Hwang; Young-Man Kwon; Jong Seok Lee; Si-Eun Yoo; Yu-Na Lee; Eun-Ju Ko; Min-Chul Kim; Min-Kyoung Cho; Young-Tae Lee; Yu-Jin Jung; Ji-Yun Lee; Jian-Dong Li; Sang-Moo Kang
Journal:  Antiviral Res       Date:  2014-08-07       Impact factor: 5.970

2.  Noninvasive monitoring of respiratory viruses in wild chimpanzees.

Authors:  Sophie Köndgen; Svenja Schenk; Georg Pauli; Christophe Boesch; Fabian H Leendertz
Journal:  Ecohealth       Date:  2010-09-24       Impact factor: 3.184

3.  High frequency of repeated infections due to emerging genotypes of human respiratory syncytial viruses among children during eight successive epidemic seasons in Japan.

Authors:  Masahiro Yamaguchi; Yasuko Sano; Isolde C Dapat; Reiko Saito; Yasushi Suzuki; Akihiko Kumaki; Yugo Shobugawa; Clyde Dapat; Makoto Uchiyama; Hiroshi Suzuki
Journal:  J Clin Microbiol       Date:  2010-12-22       Impact factor: 5.948

4.  Differential pathogenesis of respiratory syncytial virus clinical isolates in BALB/c mice.

Authors:  Kate L Stokes; Michael H Chi; Kaori Sakamoto; Dawn C Newcomb; Michael G Currier; Matthew M Huckabee; Sujin Lee; Kasia Goleniewska; Carla Pretto; John V Williams; Anne Hotard; Taylor P Sherrill; R Stokes Peebles; Martin L Moore
Journal:  J Virol       Date:  2011-04-06       Impact factor: 5.103

5.  Differential response of human naive and memory/effector T cells to dendritic cells infected by respiratory syncytial virus.

Authors:  T Rothoeft; K Fischer; S Zawatzki; V Schulz; U Schauer; C Körner Rettberg
Journal:  Clin Exp Immunol       Date:  2007-09-24       Impact factor: 4.330

Review 6.  Respiratory viral infections in infants: causes, clinical symptoms, virology, and immunology.

Authors:  John S Tregoning; Jürgen Schwarze
Journal:  Clin Microbiol Rev       Date:  2010-01       Impact factor: 26.132

7.  Reducing respiratory syncytial virus (RSV) hospitalization in a lower-income country by vaccinating mothers-to-be and their households.

Authors:  Samuel Pc Brand; Patrick Munywoki; David Walumbe; Matthew J Keeling; David James Nokes
Journal:  Elife       Date:  2020-03-27       Impact factor: 8.140

8.  Subgroup prevalence and genotype circulation patterns of human respiratory syncytial virus in Belgium during ten successive epidemic seasons.

Authors:  Kalina T Zlateva; Leen Vijgen; Nathalie Dekeersmaeker; Cecilia Naranjo; Marc Van Ranst
Journal:  J Clin Microbiol       Date:  2007-07-03       Impact factor: 5.948

9.  Comparison of strain-specific antibody responses during primary and secondary infections with respiratory syncytial virus.

Authors:  Paul D Scott; Rachel Ochola; Charles Sande; Mwanajuma Ngama; Emelda A Okiro; Graham F Medley; D James Nokes; Patricia A Cane
Journal:  J Med Virol       Date:  2007-12       Impact factor: 2.327

10.  Phylodynamics and dispersal of HRSV entails its permanence in the general population in between yearly outbreaks in children.

Authors:  Hagit Katzov-Eckert; Viviane F Botosso; Eurico Arruda Neto; Paolo Marinho de Andrade Zanotto
Journal:  PLoS One       Date:  2012-10-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.